Camellia protein hydrolysate with anti-aging effect as well as preparation method and application thereof

Camellia protein hydrolysate containing characteristic peptides was prepared by alkali-soluble acid precipitation and proteolytic treatment of camellia, which solved the problem of protein failure in effective use in the prior art, and achieved the anti-aging effect of camellia extract and delayed Skin cells aging.

CN118909035AActive Publication Date: 2024-11-08完美(广东)日用品有限公司 +1

Patent Information

Application Number
CN202411233017.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-04
Publication Date
2024-11-08
Estimated Expiration
2044-09-04

AI Technical Summary

Technical Problem

The existing camellia extraction process cannot effectively dissolve its protein, resulting in the retaining of a large amount of protein substances in the extracted residue, which cannot be fully utilized, and lack of effective anti-aging components that can delay the aging of skin cells.

Method used

Camellia pollen containing characteristic peptides were prepared by mixing the camellia pollen with alkali solution, leaching and acid precipitation, combined with proteolytic lysis and ultrafiltration drying, including Leu-Pro-Phe and Leu-Leu-Leu-Gly -His and Ala-Pro characteristic peptides have anti-aging effects.

Benefits of technology

The prepared camellia protein hydrolysate has the effect of reducing the positive rate of SA-β-Gal in cells, delaying the aging of skin cells and skin tissues, and is safe and can be used for long-term use without side effects. It is suitable for products that are anti-skin aging and related symptoms.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118909035A_ABST
    Figure CN118909035A_ABST
Patent Text Reader

Abstract

The invention relates to a camellia peptide as well as a preparation method and application thereof, and belongs to the technical field of biology. The invention provides a camellia peptide. The camellia peptide comprises a characteristic peptide, wherein the amino acid sequence of the characteristic peptide is at least one of Leu-Pro-Phe, Leu-Leu-Leu-Gly-His and Ala-Pro, and the amino acid sequence of the characteristic peptide is at least one of Leu-Pro-Phe, Leu-Leu-Leu-Leu-Gly-His and Ala-Pro. According to the invention, camellia is treated to obtain the camellia peptide, and the camellia peptide is identified by HPLC-MS / MS (High Performance Liquid Chromatography-Mass Spectrometry / Mass Spectrometry) to contain characteristic peptides of which the amino acid sequences are Leu-Pro-Phe, Leu-Leu-Leu-Gly-His and Ala-Pro. Researches in recent years prove that the small-molecule active peptide composed of amino acids can be directly absorbed and utilized by the body, can provide nutrient substances required by growth and development of the human body, and also can display effective physiological functions.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of biotechnology, and in particular to a camellia protein hydrolyzate with anti-aging effect and a preparation method and application thereof. Background Art

[0002] Camellia japonica Linn. is a shrub or small tree plant of the genus Camellia (Camellia L.) of the family Theaceae, an evergreen broad-leaved tree. It is a tropical and subtropical climate tree species. Camellia likes warm and humid conditions, with an optimum growth temperature of 18-24°C and an optimum relative humidity of 60%-80%. It mostly lives in hilly areas with an altitude of 300-1100 meters. Camellia is native to China, and most of my country's camellias are distributed in areas south of the Yangtze River, such as Zhejiang, Jiangxi, Guangxi, Yunnan, Guizhou, Hunan and Guangdong. At present, the introduction and cultivation of camellia has spread to Asia, Europe, North America, Oceania, Africa and South America. The original species of camellia widely cultivated in the world mainly include three varieties: Huadong Camellia, Yunnan Camellia and Camellia sasanqua, plus the original species unique to China, Camellia chrysantha, forming four major systems of camellia. Camellia has a beautiful posture, evergreen, bright colors, rich flower shapes, long flowering period, and a long history of horticultural cultivation. It is one of the world's famous ornamental flowers and trees with high ornamental value. In addition, camellia also has high medicinal value. For example, camellia is included in the "Mongolian Medicine Volume of the Ministry of Health of the People's Republic of China" as a Mongolian medicine, and is clinically used to clear heat and relieve pain. Recent studies have shown that camellia is rich in chemical components such as flavonoids, polyphenols, triterpenes, saponins, tannins and organic acids, as well as nutrients such as vitamins, proteins, fats, amino acids and various minerals. Biological activity studies have shown that camellia has the effects of inhibiting thrombosis, alleviating myocardial ischemic damage, improving cerebral ischemic damage, and protecting gastric mucosa. Therefore, research on camellia in the fields of chemistry and biological activity has attracted more and more attention, and it shows broad application prospects in the fields of food and medicine.

[0003] Although camellia extract has been included in the 2021 version of the "Catalogue of Used Cosmetic Raw Materials" and used in product research and development, due to the characteristics of protein macromolecules, the current essence extraction process or extract preparation process cannot effectively dissolve them, and a large amount of protein substances are still retained in the residue after camellia extraction, which has not been fully utilized. Therefore, it is urgent to develop a processing process that can hydrolyze the protein in camellia or camellia residue into small molecule peptides to enhance the application range of camellia. Summary of the invention

[0004] The purpose of the present invention is to overcome the shortcomings of the prior art and provide a camellia protein hydrolyzate with anti-aging effect and a preparation method and application thereof.

[0005] To achieve the above object, the technical solution adopted by the present invention is:

[0006] In a first aspect, the present invention provides a camellia protein hydrolyzate with anti-aging effects, comprising a characteristic peptide having an amino acid sequence of at least one of Leu-Pro-Phe, Leu-Leu-Leu-Leu-Gly-His and Ala-Pro.

[0007] The present invention finds through cell experiments that camellia peptides and camellia protein hydrolysates containing camellia peptides have the effect of reducing the cell SA-β-Gal positivity rate, indicating that they both have anti-aging activity, can delay the aging of skin cells and skin tissues, and have the advantages of safety, long-term use, and no side effects, and can be applied to products for resisting skin aging and its related symptoms.

[0008] As a preferred embodiment of the camellia protein hydrolysate of the present invention, the mass ratio of the characteristic peptide Leu-Pro-Phe, the characteristic peptide Leu-Leu-Leu-Leu-Gly-His and the characteristic peptide Ala-Pro of the camellia peptide in the camellia protein hydrolysate is Leu-Pro-Phe:Leu-Leu-Leu-Leu-Gly-His:Ala-Pro=(93.5-94):(0.4-0.5):(5.4-6).

[0009] In a second aspect, the present invention provides a method for preparing the camellia protein hydrolysate, comprising the following steps:

[0010] (1) mixing camellia pollen with an alkaline solution, extracting twice, combining the extracts, and centrifuging to obtain a supernatant;

[0011] (2) mixing the supernatant obtained in step (1) with the acid solution, allowing the mixture to stand, and centrifuging to obtain a precipitate;

[0012] (3) dissolving the precipitate obtained in step (2) in water, adjusting the pH to 6.0-8.0, adding protease, bathing at 45-55° C. for 4-8 hours, and centrifuging to obtain an enzymatic solution;

[0013] (4) The enzymatic hydrolyzate obtained in step (3) is ultrafiltered and dried to obtain a camellia protein hydrolyzate, wherein the camellia protein hydrolyzate contains camellia peptides.

[0014] The invention conducts amino acid analysis on the prepared camellia protein hydrolysate and finds that the main amino acids in the camellia protein hydrolysate are acidic amino acids. Therefore, an alkali dissolution and acid precipitation method is adopted to extract camellia protein from camellia, and the camellia protein is subjected to proteolysis, ultrafiltration and drying treatment to prepare camellia protein hydrolysate containing camellia peptides. In vivo and in vitro experiments verify that the camellia protein hydrolysate has excellent anti-aging effects.

[0015] As a preferred embodiment of the preparation method of the present invention, it includes at least one of the following (I) to (II):

[0016] (I) In step (1), the alkaline solution is a 0.3 M NaOH solution, and the ratio of camellia pollen to alkaline solution is camellia pollen: alkaline solution = 1 g: 20 mL;

[0017] (II) In step (1), the leaching is performed in a water bath at 55°C for 1 hour.

[0018] As a preferred embodiment of the preparation method of the present invention, it includes at least one of the following (III) to (IV):

[0019] (III) In step (2), the acid solution is a 0.5 M HCl solution;

[0020] (IV) In step (2), after the supernatant is mixed with the acid solution, the pH is adjusted to 3.0.

[0021] As a preferred embodiment of the preparation method of the present invention, it includes at least one of the following (V) to (VI):

[0022] (V) in step (3), the type of protease comprises at least one of papain, trypsin, flavor protease and bromelain;

[0023] (VI) In step (3), the amount of protease added is 6000 U / g.

[0024] The protease used in the enzymatic hydrolysis process of the preparation method of the present invention can be implemented by a combination of various proteases, such as a combination of papain and trypsin, a combination of papain and flavor protease, a combination of papain and bromelain, and the like.

[0025] As a preferred embodiment of the preparation method of the present invention, in step (4), the ultrafiltration is to place the enzymatic hydrolyzate obtained in step (3) in an ultrafiltration membrane for ultrafiltration separation, and the molecular weight cutoff of the ultrafiltration membrane is 2500-3000Da.

[0026] As a preferred embodiment of the preparation method of the present invention, in step (1), the method for preparing camellia pollen includes any one of the following methods:

[0027] Method 1: Air-dry the camellia naturally, crush it and pass it through a 40-mesh sieve to obtain camellia pollen;

[0028] Method 2: Place the camellia at 100°C for 15 minutes, dry at 55°C until the moisture content is less than 13%, grind and sieve through a 40-mesh sieve to obtain camellia pollen.

[0029] As a preferred embodiment of the preparation method of the present invention, in step (1), the raw material of the camellia pollen includes whole camellia flowers, and residues produced by the preparation of essences, essential oils or extracts from camellia. The present invention can hydrolyze proteins in camellia or camellia residues, and can reuse camellia residues, further expanding the application scope of camellia and improving the economic benefits of camellia.

[0030] In a third aspect, the present invention provides a camellia peptide, comprising a characteristic peptide having an amino acid sequence of at least one of Leu-Pro-Phe, Leu-Leu-Leu-Leu-Gly-His and Ala-Pro.

[0031] The present invention obtains camellia peptides by processing camellia, and HPLC-MS / MS identifies that the camellia peptides contain characteristic peptides with amino acid sequences of Leu-Pro-Phe, Leu-Leu-Leu-Leu-Gly-His and Ala-Pro. Recent studies have shown that small molecule active peptides composed of amino acids can be directly absorbed and utilized by the body, which can not only provide nutrients required for human growth and development but also show effective physiological functions.

[0032] As a preferred embodiment of the camellia peptide of the present invention, the amino acid sequence of the characteristic peptide in the camellia peptide is Leu-Pro-Phe, Leu-Leu-Leu-Leu-Gly-His and Ala-Pro.

[0033] In a fourth aspect, the present invention provides the use of the camellia peptide or the camellia protein hydrolyzate having anti-aging effect in the preparation of anti-aging products.

[0034] As a preferred embodiment of the application of the present invention, the products include medicines, foods, health products, cosmetics and biological products.

[0035] As a preferred embodiment of the application of the present invention, the dosage of the camellia protein hydrolysate is 250-1000 mg per 1 kg body weight of the organism.

[0036] As a preferred embodiment of the application of the present invention, the anti-aging product is an anti-skin aging product.

[0037] As a preferred embodiment of the present invention, the anti-skin aging includes intrinsic aging caused by age increase or genetic changes and premature aging caused by the external environment. The external stimulus includes but is not limited to sunlight exposure, pollutant stimulation, drug side effects, metabolic diseases, oxidant stimulation, emotional factors, malnutrition, and bad living habits such as smoking, drinking, lack of exercise, and staying up late.

[0038] In a fourth aspect, the present invention provides an anti-aging cosmetic comprising the camellia protein hydrolyzate or camellia peptide.

[0039] Compared with the prior art, the present invention has the following beneficial effects:

[0040] 1. The present invention obtains camellia peptides by processing camellia, and HPLC-MS / MS is used to identify that the camellia peptides contain characteristic peptides with amino acid sequences of Leu-Pro-Phe, Leu-Leu-Leu-Leu-Gly-His and Ala-Pro.

[0041] 2. The present invention has found through cell experiments that camellia peptides and camellia protein hydrolysates containing camellia peptides have the effect of reducing the cell SA-β-Gal positivity rate, indicating that they both have anti-aging activity, can delay the aging of skin cells and skin tissues, and have the advantages of safety, long-term use, and no side effects. They can be used in products for fighting skin aging and its related symptoms.

[0042] 3. The present invention conducts amino acid analysis on the prepared camellia protein hydrolysate and finds that the main amino acids in the camellia protein hydrolysate are acidic amino acids. Therefore, the camellia protein is extracted from the camellia by alkali dissolution and acid precipitation method, and is subjected to proteolysis, ultrafiltration and drying to prepare the camellia protein hydrolysate containing camellia peptides. In vivo and in vitro experiments verify that the camellia protein hydrolysate has excellent anti-aging effects. BRIEF DESCRIPTION OF THE DRAWINGS

[0043] Figure 1 This is the liquid-to-quality BPC diagram of camellia protein hydrolysate in Example 1 of the present invention;

[0044] Figure 2 The secondary mass spectrum of the LPF peptide segment in Example 1 of the present invention;

[0045] Figure 3 The secondary mass spectrum of the LLLLGH peptide segment in Example 1 of the present invention;

[0046] Figure 4 This is the secondary mass spectrum of the AP peptide segment in Example 1 of the present invention. DETAILED DESCRIPTION

[0047] In order to better illustrate the purpose, technical solutions and advantages of the present invention, the present invention will be further described below in conjunction with specific embodiments.

[0048] Unless otherwise specified, other materials, reagents, etc. used in the examples can be obtained from commercial sources.

[0049] Human fibroblasts were purchased from the Cell Bank of the Chinese Academy of Sciences with the catalog number GNHu49.

[0050] The solid phase synthesis of LPF, LLLLGH and AP characteristic peptides was commissioned to a biological company.

[0051] The formula of the staining working solution in the SA-β-Gal cell staining experiment: 1 mg / mL X-gal, 5 mM potassium ferrocyanide, 5 mM magnesium chloride, 5 mM citric acid-sodium citrate buffer, pH adjusted to 6.0.

[0052] SPF female C57BL / 6J mice were purchased from Guangdong Medical Experimental Animal Center (SCXK (Yue) 2022-0002).

[0053] SPF-grade BALB / c female mice were purchased from Guangdong Medical Experimental Animal Center (SCXK (Yue) 2022-0002).

[0054] The techniques not described in detail in the following embodiments and effect examples are all commonly used techniques in the art. Please refer to "Molecular Biology Experiment Manual" (Ma Wenli, People's Military Medical Publishing House), "Molecular Biology Experiment (Second Edition)" (Zhejiang University Press), and "Cell Biology Experiment" (Yang Hongbing, Hou Lixia, Zhang Yuxi, Higher Education Press).

[0055] In the following embodiments and effect examples, "V" refers to valine (Val), "P" refers to proline (Pro), "G" refers to glycine (Gly), "H" refers to histidine (His), "R" refers to arginine (Arg), "K" refers to lysine (Lys), "I" refers to isoleucine (Ile), "F" refers to phenylalanine (Phe), "L" refers to leucine (Leu), "W" refers to tryptophan (Trp), "A" refers to alanine (Ala), "M" refers to methionine (Met), "C" refers to cysteine ​​(Cys), "N" refers to asparagine (Asn), "S" refers to serine (Ser), "Q" refers to glutamine (Gln), "Y" refers to tyrosine (Tyr), "D" refers to aspartic acid (Asp), "E" refers to glutamic acid (Glu), and "T" refers to threonine (Thr).

[0056] In the following examples, comparative examples and effect examples, LPF characteristic peptide refers to Leu-Pro-Phe characteristic peptide, LLLLGH refers to Leu-Leu-Leu-Leu-Gly-His characteristic peptide, and AP characteristic peptide refers to Ala-Pro characteristic peptide.

[0057] Example 1

[0058] This embodiment provides a camellia protein hydrolyzate and a preparation method thereof, the preparation method comprising the following steps:

[0059] S1. The camellia flowers are naturally air-dried, crushed and passed through a 40-mesh sieve, or fixed at 100°C for 15 min and then dried at 55°C until the moisture is less than 13%, and crushed and passed through a 40-mesh sieve to obtain camellia pollen;

[0060] S2, taking the camellia pollen obtained in step S1 and 0.3M NaOH solution, the ratio of camellia pollen to NaOH solution is camellia pollen: NaOH = 1g: 20mL, extracting in a 55°C water bath for 1h, repeating the extraction twice, combining the two extracts, centrifuging at 10000rpm for 10min, and obtaining a supernatant;

[0061] S3, mixing the supernatant obtained in step S2 with a 0.5 M HCl solution, adjusting the pH to 3.0, allowing to stand for precipitation, and centrifuging at 10000 rpm for 10 min to obtain a precipitate, wherein the obtained precipitate is the crude protein;

[0062] S4, add water to the precipitate obtained in step S3, add 10 mL of water for every 1 g of precipitate, stir evenly, adjust pH to 7.0 with 2M NaOH solution, place in a water bath at 50°C, add 6000 U / g of papain, stir at 300 rpm for enzymolysis for 4 h, place in a water bath at 90°C for 15 min after enzymolysis, cool to room temperature, centrifuge at 10000 rpm for 10 min, collect the supernatant, and the obtained supernatant is the enzymolysis solution;

[0063] S5. The enzymatic hydrolyzate obtained in step S4 is ultrafiltered using a laboratory membrane separation device, and the ultrafiltration membrane used has a molecular weight cutoff of 3000Da, to obtain an ultrafiltration solution with a molecular weight lower than 3000Da, and the ultrafiltration solution is spray-dried in a high-speed centrifugal spray dryer to obtain a camellia protein hydrolyzate, wherein the camellia protein hydrolyzate contains camellia peptides.

[0064] Example 2-3

[0065] Examples 2-3 respectively provide a camellia protein hydrolyzate and a preparation method thereof. The preparation method is similar to that of Example 1, except that:

[0066] Example 2: In step S4, the “placed in a water bath at 50° C.” is adjusted to “placed in a water bath at 45° C.”, and the other operations remain unchanged;

[0067] Example 3: In step S4, the "placed in a water bath at 50°C" is adjusted to "placed in a water bath at 55°C", and the other operations remain unchanged.

[0068] Embodiment 4-5

[0069] Examples 4-5 provide a camellia protein hydrolyzate and a preparation method thereof, respectively. The preparation method is similar to that of Example 1, except that:

[0070] Example 4: In step S4, the step of "adjusting pH=7.0 with 2M NaOH solution" is adjusted to "adjusting pH=6.0 with 2M NaOH solution", and the other operations remain unchanged;

[0071] Example 5: In step S4, the "adjusting pH=7.0 with 2M NaOH solution" is adjusted to "adjusting pH=8.0 with 2M NaOH solution".

[0072] Embodiment 6-9

[0073] Examples 6-9 respectively provide a camellia protein hydrolyzate and a preparation method thereof, wherein the preparation method is similar to that of Example 1, except that:

[0074] Example 6: In step S4, the "enzymolysis with stirring at 300 rpm for 4 h" is adjusted to "enzymolysis with stirring at 300 rpm for 5 h", and the other operations remain unchanged;

[0075] Example 7: In step S4, the "enzymolysis with stirring at 300 rpm for 4 h" is adjusted to "enzymolysis with stirring at 300 rpm for 6 h", and the other operations remain unchanged;

[0076] Example 8: In step S4, the "enzymolysis with stirring at 300 rpm for 4 h" is adjusted to "enzymolysis with stirring at 300 rpm for 7 h", and the other operations remain unchanged;

[0077] Example 9: In step S4, the "enzymolysis with stirring at 300 rpm for 4 h" is adjusted to "enzymolysis with stirring at 300 rpm for 8 h", and the other operations remain unchanged.

[0078] Examples 10-12

[0079] Examples 10-12 respectively provide a camellia protein hydrolyzate and a preparation method thereof, wherein the preparation method is similar to that of Example 1, except that:

[0080] Example 10: In step S4, the step of “adding 6000 U / g of papain” is adjusted to “adding 6000 U / g of trypsin”, and the other operations remain unchanged;

[0081] Example 11: In step S4, the “adding 6000 U / g of papain” is adjusted to “adding 6000 U / g of flavor protease”, and the other operations remain unchanged;

[0082] Example 12: In step S4, the step of "adding 6000 U / g of papain" is adjusted to "adding 6000 U / g of bromelain", and the other operations remain unchanged.

[0083] Comparative Examples 1-3

[0084] Comparative Examples 1-3 respectively provide a camellia protein hydrolyzate and a preparation method thereof, wherein the preparation method is similar to that of Example 1, except that:

[0085] Comparative Example 1: In step S4, the “adding 6000 U / g of papain” was adjusted to “adding 6000 U / g of alkaline protease”, and the other operations remained unchanged;

[0086] Comparative Example 2: In step S4, the “adding 6000 U / g of papain” was adjusted to “adding 6000 U / g of neutral protease”, and the other operations remained unchanged;

[0087] Comparative Example 3: In step S4, the "addition of 6000 U / g of papain" was adjusted to "addition of 6000 U / g of composite protease", and the other operations remained unchanged.

[0088] Comparative Examples 4-6

[0089] Comparative Examples 4-6 respectively provide a camellia protein hydrolyzate and a preparation method thereof, wherein the preparation method is similar to that of Example 1, except that:

[0090] Comparative Example 4: In step S4, the “placed in a water bath at 50° C.” is adjusted to “placed in a water bath at 35° C.”, and the other operations remain unchanged;

[0091] Comparative Example 5: In step S4, the “placed in a water bath at 50° C.” is adjusted to “placed in a water bath at 40° C.”, and the other operations remain unchanged;

[0092] Comparative Example 6: In step S4, the “placing in a water bath at 50° C.” is adjusted to “placing in a water bath at 60° C.”, and the other operations remain unchanged.

[0093] Comparative Examples 7-8

[0094] Comparative Examples 7-8 respectively provide a camellia protein hydrolyzate and a preparation method thereof, wherein the preparation method is similar to that of Example 1, except that:

[0095] Comparative Example 7: In step S4, the step of "adjusting pH=7.0 with 2M NaOH solution" is adjusted to "adjusting pH=5.0 with 2M NaOH solution", and the other operations remain unchanged;

[0096] Comparative Example 8: In step S4, the “adjusting pH=7.0 with 2M NaOH solution” is adjusted to “adjusting pH=9.0 with 2M NaOH solution”.

[0097] Comparative Examples 9-10

[0098] Comparative Examples 9-10 respectively provide a camellia protein hydrolyzate and a preparation method thereof, wherein the preparation method is similar to that of Example 1, except that:

[0099] Comparative Example 9: In step S4, the "enzymolysis with stirring at 300 rpm for 4 h" was adjusted to "enzymolysis with stirring at 300 rpm for 2 h", and the other operations remained unchanged;

[0100] Comparative Example 10: In step S4, the "enzymolysis with stirring at 300 rpm for 4 h" is adjusted to "enzymolysis with stirring at 300 rpm for 3 h", and the other operations remain unchanged.

[0101] Effect Example 1

[0102] The camellia protein hydrolysate obtained in Example 1 was characterized, and the specific scheme is as follows:

[0103] 1. Determination of amino acid composition in camellia protein hydrolysate.

[0104] With reference to the national safety standard GB 5009.124-2016 Determination of amino acids in food, the amino acid content of the camellia protein hydrolysate prepared in Example 1 was analyzed using an S7130 amino acid automatic analyzer (SYKAM, Germany), with a separation column of Cation Separation Column LCA K06 / Na, 150 mm×4.6 mm; and an ammonia removal column of Ammonia Filtration Column LCA K04 / Na, 100 mm×4.6 mm. The measurement results are shown in Table 1.

[0105] Table 1 Amino acid content of camellia protein hydrolysate

[0106] Amino Acids percentage(%) Amino Acids percentage(%) Aspartic acid 10.92 Leucine 10.08 Threonine 4.25 Tyrosine 3.35 Serine 10.09 Phenylalanine 4.58 Glutamate 17.51 Histidine 2.34 Glycine 4.98 Lysine 4.67 Alanine 5.80 Arginine 4.90 Valine 5.35 Proline 6.59 Isoleucine 4.59 total 100

[0107] As shown in Table 1, camellia protein hydrolysate is rich in various amino acids, and the composition ratio of essential amino acids is relatively balanced. It has high nutritional value and is worthy of vigorous development and utilization. Glutamic acid, aspartic acid, etc. are the main amino acids in camellia protein hydrolysate and even camellia peptides, followed by serine and leucine. It can be seen that the relatively high content of acidic amino acids makes camellia protein acidic under natural conditions, and alkali dissolution and acid precipitation can effectively extract protein from camellia.

[0108] 2. The peptide sequence of the camellia protein hydrolysate obtained in Example 1 was identified.

[0109] The amino acid sequence of the camellia protein hydrolysate prepared in Example 1 was identified using the HPLC-MS / MS method. The specific detection method is as follows:

[0110] The samples were separated and detected using an X500LC-ESI-Q-TOF high-resolution liquid chromatography-mass spectrometer (AB SCIEX, USA). The liquid chromatography and mass spectrometry control software used was SCIEX OS2.0 integrated version (AB SCIEX, USA); the chromatographic column used was 1×100mm HSS T3 (1.8μm, Waters, USA).

[0111] The mobile phase consisted of 0.1% (v / v) formic acid aqueous solution (A) and acetonitrile (B), and the elution method was: 0-4.00min 5.0% B, 4.00-6.00min 5.0-10.0% B, 6.00-30.00min 10.0-40.0% B, 30.00-34.00min 40.0-90.0% B, 34.00-40.00min 90% B, 40.00-42.00min 90.0-5.0% B, 42.00-52.00min, 5.0% B, flow rate 0.05mL / min, injection volume 1μL, column temperature 40℃; mass spectrometry detection method: scan cycle 0.642s, ESI ion source temperature 500℃, positive ion mode, spray voltage 5500V, TOF primary scan range 100-1200Da, secondary scan range 50-1200Da, working mode IDA, maximum candidate ion number 4, dynamic exclusion turned on, and the rest of the parameters used the default values ​​of the proteomics method. Note that the dead volume should be minimized before using the instrument. The identification results are shown in Figure 1-4 and Table 2.

[0112] Table 2 Identification results of camellia peptide sequences in camellia protein hydrolysate

[0113]

[0114] like Figure 1-4 As shown in Table 2, the present invention identified three characteristic amino acid sequences from camellia protein hydrolysate using HPLC-MS / MS technology, including one dipeptide (AP), one tripeptide (LPF), and one hexapeptide (LLLLGH).

[0115] Effect Example 2

[0116] The anti-aging activity of the camellia protein hydrolysate obtained in Example 1 was evaluated, and the specific scheme is as follows:

[0117] The aging state of cells is assessed by detecting the activity of SA-β-Gal (Senescence-associated β-galactosidase) in the cells. Under the condition of pH 6.0, SA-β-Gal can hydrolyze the X-gal substrate to produce a blue precipitate. The activity of SA-β-Gal increases in aging cells, so after staining, a clear blue staining is presented. This method is often used in aging-related research and drug screening. This effect example uses this method to detect the anti-skin cell aging activity of the characteristic amino acid sequence of the camellia protein hydrolysate and its camellia peptide obtained in Example 1 on human fibroblasts.

[0118] This effect example selected the crude protein obtained in step S3 of Example 1, the enzymatic hydrolysate obtained in step S4 of Example 1, the components >3000Da and <3000Da obtained in step S5 of Example 1, and the solid-phase synthesized LPF, LLLLGH, and AP characteristic peptides for experiment.

[0119] Human fibroblasts were plated in a 6-well plate, and after the cells adhered overnight, they were washed twice with PBS, and 0.5 mL of PBS was added to each well to cover the cells. The ultraviolet irradiation device was placed 25 cm above the cells, the wavelength was set to 365 nm (UVA band), and the detection equipment was used for real-time monitoring. The dose of cell senescence caused by UVA was set to 5 J / cm2, and the irradiation was 15 min at a time. The cells without ultraviolet irradiation were set as the normal control group. After the illumination was completed, PBS was replaced with a complete medium containing drugs (DMEM+10% FBS), and the amount of crude protein, enzymolysate, components less than 3000 Da and components greater than 3000 Da obtained in Example 1 was added in an amount of 20 μg / mL, and the amount of LPF, LLLLGH, and AP three active peptides was added in an amount of 5 μM. After the second day, the drug-containing medium was replaced again. After the fourth day, the number of senescent cells was determined by SA-β-Gal staining.

[0120] The process of SA-β-Gal cell staining is as follows: wash the cells twice with PBS, add 1 mL of fixative solution and fix at room temperature for 5 minutes; discard the fixative solution, wash twice with PBS; add the newly prepared staining working solution, and place in a 37°C constant temperature incubator for 16 hours. Remove the colorimetric solution, wash the cells twice with PBS, and finally add 2 mL of PBS to each well, observe SA-β-Gal positive senescent cells (blue) under a microscope, and calculate the positive rate. The results are shown in Table 3.

[0121] Table 3 SA-β-Gal positive rate of human skin fibroblasts

[0122]

[0123]

[0124] As shown in Table 3, the anti-aging effect of crude protein in camellia protein hydrolysate is extremely weak, and it can only reduce the SA-β-Gal positive rate of human skin fibroblasts from 58.6% to 52.6%, while the enzymatic hydrolysate prepared by enzymatic hydrolysis can greatly improve the anti-aging activity, further reducing the SA-β-Gal positive rate to 32.1%, which shows that enzymatic hydrolysis technology can significantly enhance the anti-aging performance of camellia protein in camellia protein hydrolysate. By comparing the activity of ultrafiltration components of camellia protein hydrolysate in camellia protein hydrolysate, it was found that the SA-β-Gal positive rate of the ultrafiltration component group with a molecular weight less than 3kDa was only 11.4%, while the SA-β-Gal positive rate of the ultrafiltration component group greater than 3kDa was 45.6%, which shows that the anti-aging activity of camellia protein hydrolysate in camellia protein hydrolysate is mainly caused by components less than 3kDa. The three characteristic peptides (LPF, LLLLGH, AP) were evaluated to have strong anti-aging activity and can reduce the SA-β-Gal positive rate to less than 10%. Therefore, the three active peptides can serve as an important basis for quality control of camellia protein hydrolysate and the camellia peptides it contains.

[0125] Effect Example 3

[0126] The anti-aging activity of the camellia protein hydrolysates obtained in Examples 1-12 and Comparative Examples 1-10 was tested. The SA-β-Gal positive cell rate was tested according to the method of Effect Example 2. The results are shown in Table 4.

[0127] Table 4 Effects of different enzymatic hydrolysis processes on the anti-aging activity of camellia protein hydrolysate

[0128]

[0129]

[0130] As shown in Table 4, the anti-aging activities of camellia protein hydrolysates prepared by different processes are different. As the temperature increases, the anti-aging activity of the product increases, but when the temperature is greater than 50°C, the activity of the product is damaged, which may be related to the destruction of enzyme activity or increased side reactions caused by high temperature. Therefore, it is better to control the temperature of enzymatic hydrolysis in the range of 45-55°C, with 50°C being the optimal.

[0131] The pH of the enzymatic reaction also affects the activity of the product. The anti-aging activity of the product is better when the pH is in the range of 6.0-8.0, with pH = 7.0 being the best. This may be related to the optimal pH required for the enzymatic reaction.

[0132] In addition, as the amino acid sequence is released, the pH of the reaction system will also be affected. Therefore, choosing the most appropriate starting pH is beneficial to ensure the activity of the product.

[0133] Finally, the inventors found that the anti-aging activity of camellia protein hydrolysate requires a certain enzymatic reaction time, and at least 4 hours of camellia protein hydrolysate can reduce the SA-β-Gal positive rate of human skin fibroblasts to below 20%, but further extension of the time did not bring a significant improvement in the activity of the product. Therefore, based on considerations of energy consumption, the enzymatic hydrolysis time of 4 hours is most appropriate.

[0134] Effect Example 4

[0135] The effect of the camellia protein hydrolysate obtained in Example 1 on the photoaging mouse model was tested, and the specific scheme was as follows:

[0136] The experiment was conducted after 6-week-old SPF female C57BL / 6J mice were adaptively raised for one week in an environment with an ambient temperature of 20-25°C, a humidity of 40-60%, and daily light exposure of 12h (7:00-19:00). The back hair of all mice was removed and they were randomly divided into a normal control group, a UV model group, a low-dose camellia protein hydrolyzate (25mg / mL) group, a medium-dose camellia protein hydrolyzate (50mg / mL) group, and a high-dose camellia protein hydrolyzate (100mg / mL) group, with 8 mice in each group. Except for the normal control group, the mice in the other groups were irradiated with UVA once a day (25mJ / cm 2 ) for 8 consecutive weeks. From the day of modeling, the mice in the drug group were smeared with camellia protein hydrolyzate solution on the depilated skin every day after light exposure, 0.3 mL per mouse, and the normal control group and model group were smeared with the same volume of distilled water. After the experiment, the mice were killed by dislocation of the neck, and the back skin was collected, the subcutaneous tissue was removed, and stored in liquid nitrogen.

[0137] The level of SA-β-Gal, a marker of aging, in skin tissue was observed by histopathological sections. The specific experimental steps are as follows:

[0138] (1) Mouse skin tissue was removed from liquid nitrogen, and the skin was cooled and embedded in OCT cryosection embedding medium. The skin tissue was sliced ​​longitudinally using a cryostat with a thickness of 8 μm, and the tissue was adhered to a glass slide.

[0139] (2) Wash off the embedding agent with double distilled water, then immerse the tissue in 1% formaldehyde solution for 1 minute and wash the sections with PBS several times to remove the fixative.

[0140] (3) Add an appropriate amount of SA-β-Gal staining solution to the tissue and place it in a constant temperature incubator at 37°C to react overnight.

[0141] (4) Eosin counterstaining: Wash off the SA-β-Gal staining solution, immerse the sections in 95% ethanol to remove water for 5 seconds, then immerse the sections in eosin staining solution for 2 minutes, quickly wash the sections twice with 70% ethanol, and place them in a fume hood to dry.

[0142] (5) The tissue was sealed with neutral resin and observed and photographed under an optical microscope after solidification. SA-β-Gal positive spots appeared blue. The results are shown in Table 5.

[0143] Table 5 SA-β-Gal levels in skin tissues of photoaged mice

[0144]

[0145] As shown in Table 5, compared with the normal control group mice, the number of SA-β-Gal positive spots in the skin tissue of UV-induced photoaging mice increased significantly (from 6.80±3.74 / mm 2 Increased to 37.4±7.77 / mm 2 ), while different doses of camellia protein hydrolysate could reduce the number of SA-β-Gal positive spots. High dose (100 mg / mL) of camellia protein hydrolysate could reduce the number of SA-β-Gal positive spots to 11.5±2.56 / mm 2 The above experimental results show that applying camellia protein hydrolysate to the skin can reduce the level of aging markers in tissues and alleviate the aging process of the skin. In fact, the release of small molecule peptides formed by enzymatic hydrolysis helps to enhance the skin's absorption of it and achieve its anti-aging effect in the body.

[0146] Effect Example 5

[0147] The effect of the camellia protein hydrolysate obtained in Example 1 on the D-galactose-induced aging mouse model was tested. The specific scheme is as follows:

[0148] Six-week-old SPF BALB / c female mice (18-22g) were adaptively raised for one week in an environment with an ambient temperature of 20-25°C, a humidity of 40-60%, and a daily light of 12h (7:00-19:00) before the experiment was carried out. The mice were randomly divided into a normal control group, a D-galactose model group, a low-dose camellia protein hydrolysate (250mg / kg) group, a medium-dose camellia protein hydrolysate (500mg / kg) group, and a high-dose camellia protein hydrolysate (1000mg / kg) group, with 8 mice in each group. Except for the blank control group, the mice in the other groups were subcutaneously injected with D-galactose (500mg / kg) at the nape of the neck to prepare a subacute skin aging model, once a day for 8 consecutive weeks. From the day of modeling, camellia protein hydrolysate was given by gavage every day, and the normal control group and model group were given an equal volume of normal saline. After the experiment, the mice were killed by dislocating the neck, the hair on the back was cut, the back skin was collected, the subcutaneous tissue was removed, and the skin was stored in liquid nitrogen. The level of SA-β-Gal in the mouse skin was detected according to the method described in Effect Example 4, and the results are shown in Table 6.

[0149] Table 6D - SA-β-Gal levels in skin tissue of galactose-induced aged mice

[0150]

[0151] As shown in Table 6, compared with the normal control group mice, the number of SA-β-Gal positive points in the skin tissue of D-galactose-induced aged mice increased significantly, while different doses of camellia protein hydrolysate could reduce the number of SA-β-Gal positive points. The above experimental results show that oral intake of camellia protein hydrolysate can also achieve the aggregation of aging markers in skin tissue and alleviate the aging process of the skin.

[0152] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention rather than to limit the scope of protection of the present invention. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solution of the present invention can be modified or replaced by equivalents without departing from the essence and scope of the technical solution of the present invention.

Claims

1. A camellia protein hydrolysate with anti-aging effect, characterized in that: The invention comprises a characteristic peptide having an amino acid sequence of at least one of Leu-Pro-Phe, Leu-Leu-Leu-Leu-Gly-His and Ala-Pro.

2. The camellia protein hydrolysate according to claim 2, characterized in that The mass ratio of the characteristic peptide Leu-Pro-Phe, the characteristic peptide Leu-Leu-Leu-Leu-Gly-His and the characteristic peptide Ala-Pro of the camellia peptide in the camellia protein hydrolysate is Leu-Pro-Phe:Leu-Leu-Leu-Leu-Gly-His:Ala-Pro=(93.5-94):(0.4-0.5):(5.4-6).

3. The method for preparing camellia protein hydrolysate according to claim 1, characterized in that: The following steps are involved: (1) mixing camellia pollen with an alkaline solution, extracting twice, combining the extracts, and centrifuging to obtain a supernatant; (2) mixing the supernatant obtained in step (1) with the acid solution, allowing the mixture to stand, and centrifuging to obtain a precipitate; (3) dissolving the precipitate obtained in step (2) in water, adjusting the pH to 6.0-8.0, adding protease, bathing at 45-55° C. for 4-8 hours, and centrifuging to obtain an enzymatic solution; (4) The enzymatic hydrolyzate obtained in step (3) is ultrafiltered and dried to obtain camellia protein hydrolyzate, wherein the camellia protein hydrolyzate contains camellia peptides.

4. The preparation method according to claim 3, characterized in that: Including at least one of the following (I) to (II): (I) In step (1), the alkaline solution is a 0.3-0.5M NaOH solution, and the ratio of camellia pollen to alkaline solution is camellia pollen: alkaline solution = 1 g: (15-20) mL; (II) In step (1), the leaching is performed in a water bath at 55°C for 1-1.5 hours.

5. The preparation method according to claim 3, characterized in that: Including at least one of the following (III) to (IV): (III) In step (2), the acid solution is a 0.5-0.7 M HCl solution; (IV) In step (2), after the supernatant is mixed with the acid solution, the pH is adjusted to 3.0-4.

0.

6. The preparation method according to claim 3, characterized in that: Including at least one of the following (V) to (VI): (V) in step (3), the type of protease comprises at least one of papain, trypsin, flavor protease and bromelain; (VI) In step (3), the amount of protease added is 5500-6000 U / g.

7. The preparation method according to claim 3, characterized in that: In step (4), the ultrafiltration is to place the enzymatic hydrolysate obtained in step (3) in an ultrafiltration membrane for ultrafiltration separation, and the cut-off molecular weight of the ultrafiltration membrane is 2500-3000Da.

8. A camellia peptide, characterized in that The camellia peptide comprises a characteristic peptide having an amino acid sequence of at least one of Leu-Pro-Phe, Leu-Leu-Leu-Leu-Gly-His and Ala-Pro.

9. Use of the camellia protein hydrolyzate according to claim 1 or the camellia peptide according to claim 8 in the preparation of anti-aging products.

10. An anti-aging cosmetic, characterized in that: It comprises the camellia protein hydrolyzate as claimed in claim 1 or the camellia peptide as claimed in claim 8.

Citation Information

Patent Citations

  • Preparation method of tea pollen protein isolate

    CN109349415A

  • Method for preparing rapeseed meal oligopeptide by combining superfine grinding with one-step enzymolysis method

    CN116178487A

  • Preparation and application of polypeptide in mixed distillation fraction

    CN118146295A

  • Camellia molecular peptide (NUWAS) organic composition having effective moisturizing, soothing and repair

    WO2024125116A1

Cited By

  • Ginseng peptide as well as preparation method and application thereof

    CN119080873A

  • Ginseng peptide and its preparation method and application

    CN119080873B

  • Application of camellia pollen or camellia pollen extract and pharmaceutical composition for preventing or treating gastric mucosa intestinal metaplasia

    CN119367442A

  • Method for preparing camellia polypeptide liquid with remolded extracellular matrix protein network by two-step enzymolysis method and application of camellia polypeptide liquid

    CN121737242A